ImProDia Overview
Improdia is a diagnostic company that develops clusters of novel proprietary biomarkers for monitoring the immunity status of patients suffering from diseases associated with chronic inflammation. The technology enables the tracking of disease regression, recurrence and treatment response, and immunity status. The technology will help to identify patients who are most likely to benefit from a particular therapeutic treatment and to predict the occurrence of complications before they are evident. Improdia's technology has potential as a prognostic/diagnostic kit for a wide range of chronic inflammatory diseases and as a key tool for pharmaceutical companies in the development of new drugs for cancer, Alzheimer's disease, heart disease, rheumatology, and pulmonary diseases. Improdia's R&D focuses on developing a clinical prototype that can be successfully used in multi-center trials. The emphasis of the work revolves around product establishment and characterization, process standardization, and quality control validation. Improdia was established based on a project conceived in the Department of Immunology under Professor Michal Baniyash at the Hebrew University of Jerusalem.
Cumulative Funding Raised Over Time ($)
Latest News
No news articles.
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $200K |
| Last funding | Undisclosed |
| Stage | Seed |
| Rounds | 2 |
| Investors | 1 |
Team Members
4
Employees: 1-10
Web & Social Links
| Website | www.improdia.co.il |
Locations
Hahoshlim Street 6, Herzliya, Israel
Photos & Videos
No files yet
ImProDia Business
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & ScreeningTarget Customer
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticalsHealthcareLaboratoriesCore Technology
BiologicalsTags (13)
cancermedical-technologiesoncologybiomarkersimmunologyblood-testdiagnosticsbiotechnologyinflammatory-diseaseslaboratoriesnon-invasivepersonalized-medicineautoimmune-diseasesGeographic Markets
EuropeIndiaImProDia Financials
Cumulative Funding Raised Over Time ($)
Private Equity Funding
Non-Equity Funding
ImProDia Lifecycle
Cumulative Funding Raised Over Time
All Events
ImProDia News
0 articlesNo news articles.
ImProDia Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 1 |
| Team members | 4 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 10 classification IDs that could be used for matching.
ImProDia Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 96/100 |
| Missing | video or image, news, markets |
| BI Verification | Jenny Sotnik-Talisman |
| Registrar ID | 514694249 |
| Crunchbase | improdia |
| Phone | +97297711806 |
| Creator | Tuvia Sofinzon |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2023-08-16T00:00:00.000Z |
| Created | 2014-07-06T00:00:00.000Z |
| Claimed | Yes |